A RANDOMIZED CONTROLLED PHASE II CLINICAL TRIAL OF MODULATION OF INTER-261095130
IC Name
NATIONAL CANCER INSTITUTE
-
Activity
N01
-
Administering IC
CA
-
Application Type
5
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
-
Sub Project Total Cost
-
ARRA Funded
-
CFDA Code
-
Ed Inst. Type
-
Funding ICs
-
Funding Mechanism
-
Study Section
-
Study Section Name